EP3370822B1 - Implantable medical devices having resilient mounting tabs - Google Patents

Implantable medical devices having resilient mounting tabs Download PDF

Info

Publication number
EP3370822B1
EP3370822B1 EP15794439.8A EP15794439A EP3370822B1 EP 3370822 B1 EP3370822 B1 EP 3370822B1 EP 15794439 A EP15794439 A EP 15794439A EP 3370822 B1 EP3370822 B1 EP 3370822B1
Authority
EP
European Patent Office
Prior art keywords
mounting tab
implantable medical
aperture
bone
medical device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15794439.8A
Other languages
German (de)
French (fr)
Other versions
EP3370822A1 (en
Inventor
Sarah Elizabeth Clabeaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Bionics AG
Original Assignee
Advanced Bionics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Bionics AG filed Critical Advanced Bionics AG
Publication of EP3370822A1 publication Critical patent/EP3370822A1/en
Application granted granted Critical
Publication of EP3370822B1 publication Critical patent/EP3370822B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0541Cochlear electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36036Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the outer, middle or inner ear
    • A61N1/36038Cochlear stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/37518Anchoring of the implants, e.g. fixation
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04RLOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
    • H04R25/00Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
    • H04R25/60Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles
    • H04R25/604Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles of acoustic or vibrational transducers

Definitions

  • the present disclosure relates generally to implantable medical devices such as, for example, the implantable portion of implantable cochlear stimulation systems.
  • a wide variety of medical devices may be implanted within a patient and secured to a portion of the body (e.g., bone or other tissue) to prevent post implantation movement of the medical device.
  • a portion of the body e.g., bone or other tissue
  • cochlear implant an implantable cochlear stimulator
  • Other exemplary implantable medical devices include, but are not limited to, cardiac pacemakers, defibrillators, recording devices, neuromuscular stimulators, drug infusion pumps and deep brain stimulators.
  • ICS systems are used to help the profoundly deaf perceive a sensation of sound by directly exciting the intact auditory nerve with controlled impulses of electrical current.
  • Ambient sound pressure waves are picked up by an externally worn microphone and converted to electrical signals.
  • the electrical signals are processed by a sound processor, converted to a pulse sequence having varying pulse widths and/or amplitudes, and transmitted to an implanted receiver circuit of the ICS system.
  • the implanted receiver circuit is connected to an implantable electrode array is carried on a lead that has been inserted into the cochlea of the inner ear, and electrical stimulation current is applied to varying electrode combinations to create a perception of sound.
  • the electrode array may, alternatively, be directly inserted into the cochlear nerve without residing in the cochlea.
  • Some ICS systems include a cochlear implant, a sound processor unit (e.g., a body worn processor or behind-the-ear processor), and a microphone that is part of, or is in communication with, the sound processor unit.
  • the cochlear implant communicates with the sound processor unit and, some ICS systems include a headpiece that is in communication with both the sound processor unit and the cochlear implant.
  • the headpiece communicates with the cochlear implant by way of a transmitter (e.g., an antenna) on the headpiece and a receiver (e.g., an antenna) on the implant.
  • a transmitter e.g., an antenna
  • a receiver e.g., an antenna
  • ICS sound processors include, but are not limited to, the Advanced BionicsTM HarmonyTM BTE sound processor, the Advanced BionicsTM NaidaTM BTE sound processor and the Advanced BionicsTM NeptuneTM body worn sound processor.
  • Various techniques may be employed to prevent movement of medical devices after they have been surgically implanted.
  • such techniques include drilling a bone bed into the skull in the shape of the cochlear implant, drilling bone anchors into the skull and using the bone anchors to anchor sutures that extend over the implant, forming a tight pocket for the device in the periosteum, and drilling bone screws through one or more portions of the implant and into the skull.
  • the present inventor has determined that these conventional techniques are susceptible to improvement. With respect to drilling bone beds, this technique significantly extends the duration of the associated surgical procedure, requires a unique sizing gauge for each implant device, requires a great deal of surgical skill, and is especially difficult in the pediatric context due to the thinness of the skull.
  • US 2012/296444 A1 and AU 2013263808 B2 relate to an implantable medical device according to the preamble of claim 1, wherein a flange and suture tabs having holes for accommodating bone screws to mount the package to the cranium may be made of silicone elastomer which remains flexible enough to accommodate implantation and to adapt to variations in the curvature of a particular site.
  • the invention relates to an implantable medical device as defined in claim 1. Further aspects and preferred embodiments are defined in the appended claims. Aspects, embodiments and examples of the present disclosure which do not fall under the scope of the appended claims do not form part of the invention and are merely provided for illustrative purposes. Furthermore, the methods presented in the present description are provided for illustrative purposes only and do not form part of the present invention.
  • the implantable medical device may be a cochlear implant.
  • the present inventions also include systems with such a cochlear implant in combination with a sound processor.
  • an implanted and anchored medical device such as a cochlear implant
  • Implantable medical devices in accordance with the present inventions include an operative portion, which includes components that perform a medical function (e.g., stimulating the cochlea or stimulating heart tissue), and one or more mounting tabs that secure the operative portion to a tissue structure.
  • a medical function e.g., stimulating the cochlea or stimulating heart tissue
  • mounting tabs that secure the operative portion to a tissue structure.
  • an implantable medical device is a cochlear implant (or "implantable cochlear stimulator"), and one example of a cochlear implant is the cochlear implant 100 illustrated in FIG. 1 .
  • the cochlear implant 100 includes a flexible housing 102 formed from a silicone elastomer or other suitable material, a processor assembly 104, a cochlear lead 106, and an antenna 108 that may be used to receive data and power by way of an external antenna that is associated with, for example, a sound processor unit.
  • the flexible housing 102 includes a processor portion 110 in which the processor assembly 104 is located and an antenna portion 112 in which the antenna 108 is located.
  • the cochlear lead 106 may include a flexible body 114, an electrode array 116 at one end of the flexible body 114, and a plurality of wires (not shown) that extend through the flexible body from the electrodes 118 (e.g., platinum electrodes) in the array 116 to the other end of the flexible body.
  • the exemplary antenna 108 is a coil antenna with one or more loops (or "turns"), and three loops are shown in the illustrated embodiment.
  • the exemplary processor assembly 104 which is connected to the electrode array 116 and antenna 108, includes a printed circuit board 120 with a stimulation processor 122 that is located within a hermetically sealed case 124.
  • the stimulation processor 122 converts stimulation data into stimulation signals that stimulate the electrodes 118 of the electrode array 116.
  • a positioning magnet 126 which is used to maintain the position of a headpiece transmitter over the antenna 108, is located within the housing 102. It is sometimes necessary to remove the magnet from the cochlear implant, and then reinsert the magnet, in situ, i.e., with the cochlear implant accessed by way of an incision in the skin. To that end, the positioning magnet 126 in the illustrated embodiment is carried within an internal magnet pocket 128 and can be inserted into, and removed from, the housing pocket by way of a magnet aperture 130 that extends through the housing top wall. The magnet 126 is larger than the magnet aperture 130, i.e., the outer diameter of the magnet is greater than the diameter of the magnet aperture.
  • the portion of the top wall between the aperture 130 and the outer edge 132 of the magnet 126 forms a retainer 134 that, absent deformation of the aperture and retainer, prevents the magnet from coming out of the housing 102.
  • the aperture 130 and retainer 134 are stretched or otherwise deformed so that the magnet 126 can pass through the aperture 130.
  • present cochlear implants not limited to those that secure a removable magnet in this manner and that other structures for securing a removable magnet may be employed.
  • the present cochlear implants are also not limited to those with removable magnets and, to the contrary, include cochlear implants with non-removable magnets and cochlear implants without magnets.
  • the exemplary cochlear implant 100 may include one or more mounting tabs 136, and there are two mounting tabs in the exemplary implementation. At least a portion of each exemplary mounting tab 136 is resilient.
  • the mounting tabs 136 may be used in combination with tissue anchors (or “anchors") that are attached to the skull to fix the position of the cochlear implant 100 in such a manner that cochlear implant can disconnected from the anchors and removed if necessary without removing, adjusting or replacing the anchors.
  • the same cochlear implant (or a replacement) may thereafter be reconnected to the same anchors without removing, adjusting or replacing the anchors.
  • the mounting tabs 136 extend outwardly from the housing 102 and, in the exemplary implementation, both mounting tabs extend outwardly from the same end of the housing as the cochlear lead 106. This location facilitates the use of a relatively short incision during the implantation and removal procedures.
  • the mounting tabs 136 each include a tab body 138 and an aperture 140.
  • tissue anchors include, but are not limited to, bone screws (e.g., standard bone screws and self-drilling bone screws) and other devices that have at least a portion which is anchored to bone, such as pins that are glued to the bone.
  • tissue anchors which are absorbed into the body after a predetermined period (e.g., six months) may be employed.
  • tissue other than bone e.g., a heart wall to which a pacemaker lead is secured
  • one exemplary anchor that may be used to anchor a medical device to tissue is an absorbable barbed suture with a head.
  • anchors with posts and heads that are larger than the posts such as bone screws 142
  • Each bone screw 142 has a shank 144 with a diameter that is similar to the diameter of aperture 140 and a head 146 with a diameter that is larger than the diameter of aperture and the diameter of the shank, as is discussed below.
  • the cochlear implant 100 is positioned in the desired location on the patient's skull.
  • the locations of the apertures 140 define the locations of the bone screws 142.
  • the bone screws 142 are inserted into the apertures 140 and driven into the bone B.
  • the thickness of the tab bodies 138 and the length of the shanks 144 may be used to set the depth to which the bone screws 142 will be driven into the bone B.
  • the aperture 140 and an adjacent portion of the tab body 138 are located between the bone B and the bone screw head 146, which secures the resilient mounting tab to the bone screw 142 and to the bone. The position of the cochlear implant 100 is thereby fixed.
  • mounting tabs 136 allow the mounting tabs to be, as noted above, disconnected from bone screws 142 without removing, adjusting or replacing the bone screws, and without tearing the tabs.
  • the resilience of at least the portion of the mounting tabs 136 adjacent to the aperture 140 allows the tabs to stretch, from the state illustrated in FIGS. 4 and 5 to the state illustrated in FIGS. 6 and 7 , in response to the application of a force F to the cochlear implant housing 102. Both the tab body 138 and the aperture 140 increase in length when the mounting tab 136 is stretched.
  • the direction of the increase in length corresponds to the direction of the force F such that the tab body 138 has elongated side portions 138a and 138b, on opposite sides of the elongated aperture 140, as well as end potions 138c and 138d.
  • the length of the aperture 140 increases by a length ⁇ L from its initial length L1 (the unstretched diameter of the aperture 140 in the illustrated embodiment) to a disconnection length L2.
  • the disconnection length L2 is one example of an aperture length which allows the tab body 138 to be maneuvered over the head 146 of the bone screw 142 to separate the mounting tab 136 from the bone screw in the manner described below.
  • the disconnection length L2 need only be long enough to allow the aperture 140 to be maneuvered past the bone screw head 146.
  • the mounting tab 136 may be lifted, twisted or otherwise maneuvered off associated bone screw 142 (or other anchor) in a variety of ways, both with and without surgical tools and with or without additional movement of the remainder of the cochlear implant 100.
  • the base portion 137 i.e., the portion between the housing 102 and the aperture 140
  • the side portions 141 and 143 and the tip portion 139 i.e., the portion between the aperture 140 and the free end of the tab body
  • FIGS. 11-13 Another exemplary removal method is illustrated in FIGS. 11-13 .
  • the stretched side portion 141 is maneuvered up and over the bone screw head 146 ( FIG. 11 ) either directly, with a finger or tool, or indirectly by twisting the cochlear implant housing 102. Movement in the direction of the arrow in FIG. 12 , coupled with additional maneuvering and the resilience of the mounting tab 136, will cause the remainder of the mounting tab to move up and over the bone screw head 146.
  • the aperture 140 will then to return to its non-stretched (or unstressed) state illustrated in FIG. 13 .
  • the process may then be repeated with the second mounting tab 136 to disconnect the cochlear implant 100 from the bone B without removing or adjusting the bone screws 142.
  • a mounting tab 136 may be attached to a bone screw 142, or other anchor, in the exemplary manner illustrated in FIGS. 14-16 when a previously removed (or new) cochlear implant is implanted.
  • a portion of the aperture 140 is placed over the bone screw head 146 ( FIG. 14 ) and the mounting tab 136 is stretched in the direction of the arrow to stretch the aperture 140.
  • the mounting tab 136 may then be maneuvered in such a manner that the bone screw head 146 is within the aperture 140 ( FIG. 15 ), and then pushed toward the bone B in the direction of the arrow.
  • the resilience of the mounting tab 136 will cause the aperture 140 to return to its non-stretched (or unstressed) state ( FIG.
  • the aperture 140 and an adjacent portion of the tab body 138 are located between the bone B and the bone screw head 146, thereby attaching the mounting tab to the bone screw 142 and securing the mounting tab 136 (and cochlear implant 100) to the bone.
  • a wide variety of mounting tab shapes, dimensions and materials may be employed so long as the resulting mounting tab is configured to function in the manner described above.
  • Exemplary aspects that, taken in combination, result in a mounting tab that is configured to function in the manner described above include the tensile strength and tear strength of the mounting tab material, the length, width and thickness of the mounting tab (or at least the portion of the mounting tab that is resilient), and the size and location of the aperture.
  • Certain dimensions may also be a function of dimensions of the anchor.
  • the head may be 1.5 to 2 times the diameter of the shank, and the diameter of the mounting tab aperture may be slightly less than, equal to, or slightly greater than the diameter of the shank to create a tight fit, a line-to-line fit, or a loose fit, each of which prevents the mounting tab from being inadvertently dislodged from the associated anchor, while allowing the mounting tab to be removed from the anchor in the manner described above.
  • the mounting tabs 136 may be integrally molded with, or separately formed from and attached to, the housing 102.
  • Suitable mounting tab materials include, but are not limited to, resilient liquid silicone rubbers such as, for example, SILPURAN® 8020 from Wacker Chemie AG.
  • the mounting tab 136 is formed from a material having a tensile strength of 10 N/mm 2 and a tear strength of 28 N/mm.
  • the width W is 5.5 mm
  • the total length L T is 5 mm
  • the end length L E from the aperture 140 to the free end of the mounting tab is 1.9 mm
  • the aperture 140 has a diameter of 1.6 mm and is centered in the width direction
  • the thickness T is 1.45 mm.
  • the present mounting tabs are not limited to configuration illustrated in FIGS. 1-18 .
  • cochlear implants 100a-100d illustrated in FIGS. 19-22 are identical to cochlear implant 100, but for the configuration of the mounting tabs 136a-136d, and similar elements are represented by similar reference numerals.
  • the thickness of the mounting tabs may vary over some or all of their lengths.
  • the exemplary mounting tab 136a in FIG. 19 has a tab body 138a with a base portion 137a having a thickness that decreases from the housing 102 to the aperture 140. The thickness of the remainder of the tab body 138a is constant.
  • the width of the mounting tabs may vary over some or all of their lengths.
  • the exemplary mounting tab 136b illustrated in FIG. 20 has a tab body 138b with a base portion 137b that has a width which decreases from the housing 102 to the aperture 140. Structures may also be embedded in or otherwise carried by the mounting tabs to alter the properties of the mounting tabs. Structures that, for example, reduce or eliminate the resiliency of a portion of the mounting tab may be employed.
  • the exemplary mounting tab 136c includes a reinforcing member 145c (e.g., Teflon mesh) in the base portion 137c that, depending on configuration, reduces or eliminates the resilience of the base portion.
  • the exemplary mounting tab 136d includes a malleable member 145d (e.g., a malleable wire) in the base portion 137d.
  • the malleable member 145d which will hold its shape after being bent, allows the surgeon to shape the mounting tab base portion 137d in a manner that conforms to the skull or other underlying tissue structure.
  • the portion of the tab body 138d with the aperture 140 and the tip portion 139c will remain resilient.
  • the present mounting tabs include mounting tabs with any and all combinations of the features in mounting tabs 136a-136d.
  • the exemplary cochlear implant system 50 includes the cochlear implant 100, a sound processor, such as the illustrated body worn sound processor 200 or a behind-the-ear sound processor, and a headpiece 300.
  • the exemplary body worn sound processor 200 in the exemplary ICS system 50 includes a housing 202 in which and/or on which various components are supported. Such components may include, but are not limited to, sound processor circuitry 204, a headpiece port 206, an auxiliary device port 208 for an auxiliary device such as a mobile phone or a music player, a control panel 210, one or microphones 212, and a power supply receptacle 214 for a removable battery or other removable power supply 216 (e.g., rechargeable and disposable batteries or other electrochemical cells).
  • the sound processor circuitry 204 converts electrical signals from the microphone 212 into stimulation data.
  • the exemplary headpiece 300 includes a housing 302 and various components, e.g., a RF connector 304, a microphone 306, an antenna (or other transmitter) 308 and a positioning magnet apparatus 310, that are carried by the housing.
  • the magnet apparatus 310 may consist of a single magnet or may consist of one or more magnets and a shim.
  • the headpiece 300 may be connected to the sound processor headpiece port 206 by a cable 312.
  • the positioning magnet apparatus 310 is attracted to the magnet 124 of the cochlear stimulator 100, thereby aligning the antenna 308 with the antenna 108.
  • the stimulation data and, in many instances power, is supplied to the headpiece 300.
  • the headpiece 300 transcutaneously transmits the stimulation data, and in many instances power, to the cochlear implant 100 by way of a wireless link between the antennas.
  • the stimulation processor 118 converts the stimulation data into stimulation signals that stimulate the electrodes 114 of the electrode array 112.
  • the cable 312 will be configured for forward telemetry and power signals at 49 MHz and back telemetry signals at 10.7 MHz. It should be noted that, in other implementations, communication between a sound processor and a headpiece and/or auxiliary device may be accomplished through wireless communication techniques. Additionally, given the presence of the microphone(s) 212 on the sound processor 200, the microphone 306 may be also be omitted in some instances. The functionality of the sound processor 200 and headpiece 300 may also be combined into a single head wearable sound processor. Examples of head wearable sound processors are illustrated and described in U.S. Patent Nos. 8,811,643 and 8,983,102 .
  • cochlear implants are merely one example of a type of implantable medical device that benefits from the present inventions.
  • Other exemplary implantable medical devices that may be provided with the present resilient mounting tabs, and be disconnected and connected to bone anchors in the manner described above, include, but are not limited to, cardiac pacemakers, defibrillators, recording devices, neuromuscular stimulators drug infusion pumps and deep brain stimulators.

Description

    BACKGROUND 1. Field
  • The present disclosure relates generally to implantable medical devices such as, for example, the implantable portion of implantable cochlear stimulation systems.
  • 2. Description of the Related Art
  • A wide variety of medical devices may be implanted within a patient and secured to a portion of the body (e.g., bone or other tissue) to prevent post implantation movement of the medical device. Although the present inventions are not so limited, one such implantable device is an implantable cochlear stimulator (or "cochlear implant"), and the present inventions are described primarily in the context of cochlear implants. Other exemplary implantable medical devices include, but are not limited to, cardiac pacemakers, defibrillators, recording devices, neuromuscular stimulators, drug infusion pumps and deep brain stimulators.
  • ICS systems are used to help the profoundly deaf perceive a sensation of sound by directly exciting the intact auditory nerve with controlled impulses of electrical current. Ambient sound pressure waves are picked up by an externally worn microphone and converted to electrical signals. The electrical signals, in turn, are processed by a sound processor, converted to a pulse sequence having varying pulse widths and/or amplitudes, and transmitted to an implanted receiver circuit of the ICS system. The implanted receiver circuit is connected to an implantable electrode array is carried on a lead that has been inserted into the cochlea of the inner ear, and electrical stimulation current is applied to varying electrode combinations to create a perception of sound. The electrode array may, alternatively, be directly inserted into the cochlear nerve without residing in the cochlea.
  • Some ICS systems include a cochlear implant, a sound processor unit (e.g., a body worn processor or behind-the-ear processor), and a microphone that is part of, or is in communication with, the sound processor unit. The cochlear implant communicates with the sound processor unit and, some ICS systems include a headpiece that is in communication with both the sound processor unit and the cochlear implant. The headpiece communicates with the cochlear implant by way of a transmitter (e.g., an antenna) on the headpiece and a receiver (e.g., an antenna) on the implant. A representative ICS system is disclosed in U.S. Patent No. 5,824,022 , which is entitled "Cochlear Stimulation System Employing Behind-The-Ear Sound processor With Remote Control". Examples of commercially available ICS sound processors include, but are not limited to, the Advanced Bionics™ Harmony™ BTE sound processor, the Advanced Bionics™ Naida™ BTE sound processor and the Advanced Bionics™ Neptune™ body worn sound processor.
  • Various techniques may be employed to prevent movement of medical devices after they have been surgically implanted. In the exemplary context of cochlear implants, such techniques include drilling a bone bed into the skull in the shape of the cochlear implant, drilling bone anchors into the skull and using the bone anchors to anchor sutures that extend over the implant, forming a tight pocket for the device in the periosteum, and drilling bone screws through one or more portions of the implant and into the skull. The present inventor has determined that these conventional techniques are susceptible to improvement. With respect to drilling bone beds, this technique significantly extends the duration of the associated surgical procedure, requires a unique sizing gauge for each implant device, requires a great deal of surgical skill, and is especially difficult in the pediatric context due to the thinness of the skull. Suturing across the implant from one anchor to another is also quite time consuming and the suture ends can sometimes become irritants. Tight pockets do not always prevent implant migration. With respect to bone screws that extend through the implant, the bone screws tend to become permanently integrated into the bone, which can be problematic should implant removal become necessary. Here, the bone screws must be drilled out of the bone and, when the removed implant (or a replacement implant) is subsequently implanted, the new bone screws must be offset from the prior bone screw locations. As a result, the cochlear implant, including the lead that carries the electrode array, must be repositioned.
  • US 2012/296444 A1 and AU 2013263808 B2 relate to an implantable medical device according to the preamble of claim 1, wherein a flange and suture tabs having holes for accommodating bone screws to mount the package to the cranium may be made of silicone elastomer which remains flexible enough to accommodate implantation and to adapt to variations in the curvature of a particular site.
  • SUMMARY
  • The invention relates to an implantable medical device as defined in claim 1. Further aspects and preferred embodiments are defined in the appended claims. Aspects, embodiments and examples of the present disclosure which do not fall under the scope of the appended claims do not form part of the invention and are merely provided for illustrative purposes. Furthermore, the methods presented in the present description are provided for illustrative purposes only and do not form part of the present invention. In some instances, the implantable medical device may be a cochlear implant. The present inventions also include systems with such a cochlear implant in combination with a sound processor.
  • There are a number of advantages associated with such apparatus. For example, an implanted and anchored medical device (such as a cochlear implant) may be readily disconnected from one or more anchors (such as bone screws) and removed from the patient without removing, adjusting or replacing the anchors.
  • The above described and many other features of the present inventions will become apparent as the inventions become better understood by reference to the following detailed description when considered in conjunction with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Detailed descriptions of the exemplary embodiments will be made with reference to the accompanying drawings.
    • FIG. 1 is a plan view of a cochlear implant in accordance with one embodiment of a present invention.
    • FIG. 2 is a plan view of a portion of the cochlear implant illustrated in FIG. 1.
    • FIG. 3 is a side view of a portion of the cochlear implant illustrated in FIG. 1.
    • FIG. 4 is a plan view of a portion of the cochlear implant illustrated in FIG. 1 secured to bone.
    • FIG. 5 is a side, partial section view of a portion of the cochlear implant illustrated in FIG. 1 secured to bone.
    • FIG. 6 is a plan view of a portion of the cochlear implant illustrated in FIG. 1 secured to bone with the mounting tabs stretched.
    • FIG. 7 is a side, partial section view of a portion of the cochlear implant illustrated in FIG. 1 secured to bone with the mounting tabs stretched.
    • FIG. 8 is a plan view showing a mounting tab partially disconnected from a bone screw.
    • FIG. 9 is a plan view showing a mounting tab disconnected from a bone screw.
    • FIG. 10 is a section view showing a mounting tab disconnected from a bone screw.
    • FIG. 11 is a plan view showing a mounting tab partially disconnected from a bone screw.
    • FIG. 12 is a plan view showing a mounting tab partially disconnected from a bone screw.
    • FIG. 13 is a plan view showing a mounting tab disconnected from a bone screw.
    • FIG. 14 is a section view showing a mounting tab being connected to a bone screw.
    • FIG. 15 is another section view showing a mounting tab being connected to a bone screw.
    • FIG. 16 is a section view showing a mounting tab connected to a bone screw.
    • FIG. 17 is a plan view of a portion of the cochlear implant illustrated in FIG. 1.
    • FIG. 18 is a side view of a portion of the cochlear implant illustrated in FIG. 1.
    • FIG. 19 is a side view of a portion of a cochlear implant in accordance with one embodiment of a present invention.
    • FIG. 20 is a plan view of a portion of a cochlear implant in accordance with one embodiment of a present invention.
    • FIG. 21 is a plan view of a portion of a cochlear implant in accordance with one embodiment of a present invention.
    • FIG. 22 is a plan view of a portion of a cochlear implant in accordance with one embodiment of a present invention.
    • FIG. 23 is a block diagram of a cochlear implant system in accordance with one embodiment of a present invention.
    DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENTS
  • The following is a detailed description of the best presently known modes of carrying out the inventions. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating the general principles of the inventions.
  • Implantable medical devices in accordance with the present inventions include an operative portion, which includes components that perform a medical function (e.g., stimulating the cochlea or stimulating heart tissue), and one or more mounting tabs that secure the operative portion to a tissue structure. One example of an implantable medical device is a cochlear implant (or "implantable cochlear stimulator"), and one example of a cochlear implant is the cochlear implant 100 illustrated in FIG. 1. The cochlear implant 100 includes a flexible housing 102 formed from a silicone elastomer or other suitable material, a processor assembly 104, a cochlear lead 106, and an antenna 108 that may be used to receive data and power by way of an external antenna that is associated with, for example, a sound processor unit. The flexible housing 102 includes a processor portion 110 in which the processor assembly 104 is located and an antenna portion 112 in which the antenna 108 is located. The cochlear lead 106 may include a flexible body 114, an electrode array 116 at one end of the flexible body 114, and a plurality of wires (not shown) that extend through the flexible body from the electrodes 118 (e.g., platinum electrodes) in the array 116 to the other end of the flexible body. The exemplary antenna 108 is a coil antenna with one or more loops (or "turns"), and three loops are shown in the illustrated embodiment. The exemplary processor assembly 104, which is connected to the electrode array 116 and antenna 108, includes a printed circuit board 120 with a stimulation processor 122 that is located within a hermetically sealed case 124. The stimulation processor 122 converts stimulation data into stimulation signals that stimulate the electrodes 118 of the electrode array 116.
  • A positioning magnet 126, which is used to maintain the position of a headpiece transmitter over the antenna 108, is located within the housing 102. It is sometimes necessary to remove the magnet from the cochlear implant, and then reinsert the magnet, in situ, i.e., with the cochlear implant accessed by way of an incision in the skin. To that end, the positioning magnet 126 in the illustrated embodiment is carried within an internal magnet pocket 128 and can be inserted into, and removed from, the housing pocket by way of a magnet aperture 130 that extends through the housing top wall. The magnet 126 is larger than the magnet aperture 130, i.e., the outer diameter of the magnet is greater than the diameter of the magnet aperture. The portion of the top wall between the aperture 130 and the outer edge 132 of the magnet 126 forms a retainer 134 that, absent deformation of the aperture and retainer, prevents the magnet from coming out of the housing 102. During installation and removal, the aperture 130 and retainer 134 are stretched or otherwise deformed so that the magnet 126 can pass through the aperture 130. It should be noted, however, that the present cochlear implants not limited to those that secure a removable magnet in this manner and that other structures for securing a removable magnet may be employed. The present cochlear implants are also not limited to those with removable magnets and, to the contrary, include cochlear implants with non-removable magnets and cochlear implants without magnets.
  • Turning to FIGS. 2 and 3, the exemplary cochlear implant 100 may include one or more mounting tabs 136, and there are two mounting tabs in the exemplary implementation. At least a portion of each exemplary mounting tab 136 is resilient. The mounting tabs 136 may be used in combination with tissue anchors (or "anchors") that are attached to the skull to fix the position of the cochlear implant 100 in such a manner that cochlear implant can disconnected from the anchors and removed if necessary without removing, adjusting or replacing the anchors. The same cochlear implant (or a replacement) may thereafter be reconnected to the same anchors without removing, adjusting or replacing the anchors. The mounting tabs 136 extend outwardly from the housing 102 and, in the exemplary implementation, both mounting tabs extend outwardly from the same end of the housing as the cochlear lead 106. This location facilitates the use of a relatively short incision during the implantation and removal procedures. The mounting tabs 136 each include a tab body 138 and an aperture 140.
  • In the context of bone tissue, exemplary tissue anchors include, but are not limited to, bone screws (e.g., standard bone screws and self-drilling bone screws) and other devices that have at least a portion which is anchored to bone, such as pins that are glued to the bone. In certain situations where the formation of scar tissue will eventually hold the cochlear implant or other implanted medical device in place at the desired location, tissue anchors which are absorbed into the body after a predetermined period (e.g., six months) may be employed. With respect to tissue other than bone (e.g., a heart wall to which a pacemaker lead is secured), one exemplary anchor that may be used to anchor a medical device to tissue is an absorbable barbed suture with a head.
  • As illustrated for example in FIGS. 4 and 5, anchors with posts and heads that are larger than the posts, such as bone screws 142, may be used to secure each mounting tab 136 to bone B, thereby fixing the position of the cochlear implant 100. Each bone screw 142 has a shank 144 with a diameter that is similar to the diameter of aperture 140 and a head 146 with a diameter that is larger than the diameter of aperture and the diameter of the shank, as is discussed below. During the initial implantation procedure, the cochlear implant 100 is positioned in the desired location on the patient's skull. The locations of the apertures 140 define the locations of the bone screws 142. The bone screws 142 are inserted into the apertures 140 and driven into the bone B. The thickness of the tab bodies 138 and the length of the shanks 144 may be used to set the depth to which the bone screws 142 will be driven into the bone B. The aperture 140 and an adjacent portion of the tab body 138 are located between the bone B and the bone screw head 146, which secures the resilient mounting tab to the bone screw 142 and to the bone. The position of the cochlear implant 100 is thereby fixed.
  • The properties of mounting tabs 136, which are discussed in greater detail below, allow the mounting tabs to be, as noted above, disconnected from bone screws 142 without removing, adjusting or replacing the bone screws, and without tearing the tabs. The resilience of at least the portion of the mounting tabs 136 adjacent to the aperture 140 allows the tabs to stretch, from the state illustrated in FIGS. 4 and 5 to the state illustrated in FIGS. 6 and 7, in response to the application of a force F to the cochlear implant housing 102. Both the tab body 138 and the aperture 140 increase in length when the mounting tab 136 is stretched. The direction of the increase in length corresponds to the direction of the force F such that the tab body 138 has elongated side portions 138a and 138b, on opposite sides of the elongated aperture 140, as well as end potions 138c and 138d. Referring more specifically to FIG. 7, the length of the aperture 140 increases by a length ΔL from its initial length L1 (the unstretched diameter of the aperture 140 in the illustrated embodiment) to a disconnection length L2. The disconnection length L2 is one example of an aperture length which allows the tab body 138 to be maneuvered over the head 146 of the bone screw 142 to separate the mounting tab 136 from the bone screw in the manner described below. The disconnection length L2 need only be long enough to allow the aperture 140 to be maneuvered past the bone screw head 146.
  • After the mounting tab 136 has been stretched, the mounting tab may be lifted, twisted or otherwise maneuvered off associated bone screw 142 (or other anchor) in a variety of ways, both with and without surgical tools and with or without additional movement of the remainder of the cochlear implant 100. By way of example, but not limitation, the base portion 137 (i.e., the portion between the housing 102 and the aperture 140) may be lifted up and over the bone screw head 146 in the manner illustrated in FIG. 8. Continued movement of the mounting tab 136 in the direction of the arrow will allow the side portions 141 and 143 and the tip portion 139 (i.e., the portion between the aperture 140 and the free end of the tab body) clear the screw head 146. The resilience of the mounting tab 136 will then cause the aperture 140 to return to its non-stretched (or unstressed) state as is shown in FIGS. 9 and 10. The bone screw 142 is not removed or otherwise adjusted during this process. Another exemplary removal method is illustrated in FIGS. 11-13. Here, after the mounting tab 136 has been stretched, the stretched side portion 141 is maneuvered up and over the bone screw head 146 (FIG. 11) either directly, with a finger or tool, or indirectly by twisting the cochlear implant housing 102. Movement in the direction of the arrow in FIG. 12, coupled with additional maneuvering and the resilience of the mounting tab 136, will cause the remainder of the mounting tab to move up and over the bone screw head 146. The aperture 140 will then to return to its non-stretched (or unstressed) state illustrated in FIG. 13. The process may then be repeated with the second mounting tab 136 to disconnect the cochlear implant 100 from the bone B without removing or adjusting the bone screws 142.
  • A mounting tab 136 may be attached to a bone screw 142, or other anchor, in the exemplary manner illustrated in FIGS. 14-16 when a previously removed (or new) cochlear implant is implanted. A portion of the aperture 140 is placed over the bone screw head 146 (FIG. 14) and the mounting tab 136 is stretched in the direction of the arrow to stretch the aperture 140. The mounting tab 136 may then be maneuvered in such a manner that the bone screw head 146 is within the aperture 140 (FIG. 15), and then pushed toward the bone B in the direction of the arrow. When the aperture 140 passes the bone screw head 146, the resilience of the mounting tab 136 will cause the aperture 140 to return to its non-stretched (or unstressed) state (FIG. 16), with a diameter that is less than that of the bone screw head 146. At this point, the aperture 140 and an adjacent portion of the tab body 138 are located between the bone B and the bone screw head 146, thereby attaching the mounting tab to the bone screw 142 and securing the mounting tab 136 (and cochlear implant 100) to the bone.
  • A wide variety of mounting tab shapes, dimensions and materials may be employed so long as the resulting mounting tab is configured to function in the manner described above. Exemplary aspects that, taken in combination, result in a mounting tab that is configured to function in the manner described above include the tensile strength and tear strength of the mounting tab material, the length, width and thickness of the mounting tab (or at least the portion of the mounting tab that is resilient), and the size and location of the aperture. Certain dimensions may also be a function of dimensions of the anchor. In the exemplary context of a bone screw, the head may be 1.5 to 2 times the diameter of the shank, and the diameter of the mounting tab aperture may be slightly less than, equal to, or slightly greater than the diameter of the shank to create a tight fit, a line-to-line fit, or a loose fit, each of which prevents the mounting tab from being inadvertently dislodged from the associated anchor, while allowing the mounting tab to be removed from the anchor in the manner described above.
  • The mounting tabs 136 may be integrally molded with, or separately formed from and attached to, the housing 102. Suitable mounting tab materials include, but are not limited to, resilient liquid silicone rubbers such as, for example, SILPURAN® 8020 from Wacker Chemie AG.
  • Referring to FIGS. 17 and 18, in one exemplary configuration, the mounting tab 136 is formed from a material having a tensile strength of 10 N/mm2 and a tear strength of 28 N/mm. The width W is 5.5 mm, the total length LT is 5 mm, the end length LE from the aperture 140 to the free end of the mounting tab is 1.9 mm, the aperture 140 has a diameter of 1.6 mm and is centered in the width direction, and the thickness T is 1.45 mm.
  • The present mounting tabs are not limited to configuration illustrated in FIGS. 1-18. By way of example, but not limitation, cochlear implants 100a-100d illustrated in FIGS. 19-22 are identical to cochlear implant 100, but for the configuration of the mounting tabs 136a-136d, and similar elements are represented by similar reference numerals. For example, the thickness of the mounting tabs may vary over some or all of their lengths. To that end, the exemplary mounting tab 136a in FIG. 19 has a tab body 138a with a base portion 137a having a thickness that decreases from the housing 102 to the aperture 140. The thickness of the remainder of the tab body 138a is constant. Alternatively, or in addition, the width of the mounting tabs may vary over some or all of their lengths. The exemplary mounting tab 136b illustrated in FIG. 20, for example, has a tab body 138b with a base portion 137b that has a width which decreases from the housing 102 to the aperture 140. Structures may also be embedded in or otherwise carried by the mounting tabs to alter the properties of the mounting tabs. Structures that, for example, reduce or eliminate the resiliency of a portion of the mounting tab may be employed. The exemplary mounting tab 136c includes a reinforcing member 145c (e.g., Teflon mesh) in the base portion 137c that, depending on configuration, reduces or eliminates the resilience of the base portion. The portion of the tab body 138c with the aperture 140 remains resilient, as does the tip portion 139c that is located between the aperture 140 and the free end of the tab body. Turning to FIG. 22, the exemplary mounting tab 136d includes a malleable member 145d (e.g., a malleable wire) in the base portion 137d. The malleable member 145d, which will hold its shape after being bent, allows the surgeon to shape the mounting tab base portion 137d in a manner that conforms to the skull or other underlying tissue structure. The portion of the tab body 138d with the aperture 140 and the tip portion 139c will remain resilient. It should also be noted that the present mounting tabs include mounting tabs with any and all combinations of the features in mounting tabs 136a-136d.
  • As illustrated in FIG. 23, the exemplary cochlear implant system 50 includes the cochlear implant 100, a sound processor, such as the illustrated body worn sound processor 200 or a behind-the-ear sound processor, and a headpiece 300.
  • The exemplary body worn sound processor 200 in the exemplary ICS system 50 includes a housing 202 in which and/or on which various components are supported. Such components may include, but are not limited to, sound processor circuitry 204, a headpiece port 206, an auxiliary device port 208 for an auxiliary device such as a mobile phone or a music player, a control panel 210, one or microphones 212, and a power supply receptacle 214 for a removable battery or other removable power supply 216 (e.g., rechargeable and disposable batteries or other electrochemical cells). The sound processor circuitry 204 converts electrical signals from the microphone 212 into stimulation data. The exemplary headpiece 300 includes a housing 302 and various components, e.g., a RF connector 304, a microphone 306, an antenna (or other transmitter) 308 and a positioning magnet apparatus 310, that are carried by the housing. The magnet apparatus 310 may consist of a single magnet or may consist of one or more magnets and a shim. The headpiece 300 may be connected to the sound processor headpiece port 206 by a cable 312. The positioning magnet apparatus 310 is attracted to the magnet 124 of the cochlear stimulator 100, thereby aligning the antenna 308 with the antenna 108. The stimulation data and, in many instances power, is supplied to the headpiece 300. The headpiece 300 transcutaneously transmits the stimulation data, and in many instances power, to the cochlear implant 100 by way of a wireless link between the antennas. The stimulation processor 118 converts the stimulation data into stimulation signals that stimulate the electrodes 114 of the electrode array 112.
  • In at least some implementations, the cable 312 will be configured for forward telemetry and power signals at 49 MHz and back telemetry signals at 10.7 MHz. It should be noted that, in other implementations, communication between a sound processor and a headpiece and/or auxiliary device may be accomplished through wireless communication techniques. Additionally, given the presence of the microphone(s) 212 on the sound processor 200, the microphone 306 may be also be omitted in some instances. The functionality of the sound processor 200 and headpiece 300 may also be combined into a single head wearable sound processor. Examples of head wearable sound processors are illustrated and described in U.S. Patent Nos. 8,811,643 and 8,983,102 .
  • It should also be noted that cochlear implants are merely one example of a type of implantable medical device that benefits from the present inventions. Other exemplary implantable medical devices that may be provided with the present resilient mounting tabs, and be disconnected and connected to bone anchors in the manner described above, include, but are not limited to, cardiac pacemakers, defibrillators, recording devices, neuromuscular stimulators drug infusion pumps and deep brain stimulators.
  • Although the inventions disclosed herein have been described in terms of the preferred embodiments above, numerous modifications and/or additions to the above-described preferred embodiments would be readily apparent to one skilled in the art. By way of example, but not limitation, the inventions include any combination of the elements from the various species and embodiments disclosed in the specification that are not already described. It is intended that the scope of the present inventions extend to all such modifications and/or additions and that the scope of the present inventions is limited solely by the claims set forth below.

Claims (8)

  1. An implantable medical device for use with an anchor (142), having a post (144) and a head (146) that is larger than the post, which is secured to a tissue structure, the implantable medical device comprising:
    an operative portion (102, 104, 106, 108); and
    at least one mounting tab (136, 136a, 136b, 136c, 136d) associated with the operative portion and having an aperture (140) that is configured to receive the post,
    characterized by at least a portion of the mounting tab being configured to stretch, in a first direction without tearing, from a first size (L1) where the aperture is smaller than the anchor head to a second size (L2) that is larger than the first size in the first direction and that allows the aperture to fit over the anchor head.
  2. An implantable medical device as claimed in claim 1, wherein
    the at least one mounting tab (136, 136a, 136b, 136c, 136d) comprises a plurality of mounting tabs.
  3. An implantable medical device as claimed in claim 1, wherein
    the operative portion includes a cochlear lead (106), an antenna (108), and a stimulation processor (122) within the housing operably connected to the antenna and to the cochlear lead.
  4. An implantable medical device as claimed in claim 1, wherein
    the entire mounting tab (136, 136a, 136b) is formed from resilient material.
  5. An implantable medical device as claimed in claim 1, wherein
    the mounting tab (136, 136a) defines a length, a width and a thickness, and the width and/or thickness varies over at least a portion of the length.
  6. An implantable medical device as claimed in claim 1, wherein
    the mounting tab (136c) includes resilient material and a reinforcing member (145c) within the resilient material.
  7. An implantable medical device as claimed in claim 1, wherein
    the mounting tab (136d) includes resilient material and a malleable member (145d) within the resilient material.
  8. A system, comprising:
    an anchor (142) having a post (144) and a head (146) that is larger than the post; and
    an implantable medical device as claimed in any one of claims claim 1-7.
EP15794439.8A 2015-11-05 2015-11-05 Implantable medical devices having resilient mounting tabs Active EP3370822B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2015/059270 WO2017078720A1 (en) 2015-11-05 2015-11-05 Implantable medical devices having resilient mounting tabs and associated methods

Publications (2)

Publication Number Publication Date
EP3370822A1 EP3370822A1 (en) 2018-09-12
EP3370822B1 true EP3370822B1 (en) 2020-10-14

Family

ID=54541246

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15794439.8A Active EP3370822B1 (en) 2015-11-05 2015-11-05 Implantable medical devices having resilient mounting tabs

Country Status (3)

Country Link
US (1) US10894156B2 (en)
EP (1) EP3370822B1 (en)
WO (1) WO2017078720A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11173299B2 (en) 2018-12-03 2021-11-16 Advanced Bionics Ag Electrode leads configured to engage with a fixing element and methods for manufacturing the same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5249574A (en) 1991-01-15 1993-10-05 Ventritex, Inc. Implantation of leads
US5824022A (en) 1996-03-07 1998-10-20 Advanced Bionics Corporation Cochlear stimulation system employing behind-the-ear speech processor with remote control
US6078841A (en) * 1998-03-27 2000-06-20 Advanced Bionics Corporation Flexible positioner for use with implantable cochlear electrode array
US7238203B2 (en) * 2001-12-12 2007-07-03 Vita Special Purpose Corporation Bioactive spinal implants and method of manufacture thereof
WO2003076012A1 (en) 2002-03-08 2003-09-18 Cochlear Limited A cochlear implant
AU2002950755A0 (en) 2002-08-09 2002-09-12 Cochlear Limited Fixation system for a cochlear implant
AU2003901867A0 (en) 2003-04-17 2003-05-08 Cochlear Limited Osseointegration fixation system for an implant
US8270647B2 (en) 2003-05-08 2012-09-18 Advanced Bionics, Llc Modular speech processor headpiece
US8811643B2 (en) 2003-05-08 2014-08-19 Advanced Bionics Integrated cochlear implant headpiece
US20080195178A1 (en) * 2003-12-30 2008-08-14 Kuzma Janusz A Fixation methods and systems for cochlear implant component or other implantable devices
MXPA06014064A (en) * 2004-06-02 2007-07-13 Kfx Medical Corp System and method for attaching soft tissue to bone.
WO2007053882A1 (en) 2005-11-10 2007-05-18 Cochlear Limited Arrangement for the fixation of an implantable medical device
AU2013263808B2 (en) * 2007-07-27 2015-07-16 Second Sight Medical Products Implantable device for the brain
US8262624B2 (en) * 2008-03-27 2012-09-11 Medtronic, Inc. Anchor and anchor deployment apparatus
WO2012158834A1 (en) * 2011-05-16 2012-11-22 Second Sight Medical Products, Inc. Cortical interface with an electrode array divided into separate fingers and/or with a wireless transceiver
EP2537555B1 (en) * 2011-06-24 2013-05-01 Sorin CRM SAS Leadless autonomous intracardiac implant with disengageable attachment element
EP3131312A1 (en) 2013-11-25 2017-02-15 Oticon Medical A/S Hearing aid interconnection system
US20150164498A1 (en) * 2013-12-11 2015-06-18 Arthrex, Inc. Suture washer
US20190099173A1 (en) 2017-10-02 2019-04-04 Med-El Elektromedizinische Geraete Gmbh Implant Fixation with Suture Anchors
US11458301B2 (en) * 2018-05-04 2022-10-04 Medtronic, Inc. Fixation device for medical device retention

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
WO2017078720A1 (en) 2017-05-11
US10894156B2 (en) 2021-01-19
EP3370822A1 (en) 2018-09-12
US20180236250A1 (en) 2018-08-23

Similar Documents

Publication Publication Date Title
US11351364B2 (en) Apparatus, system, and method for selective stimulation
US20220233869A1 (en) Implantable device having one or more screws
US8126564B2 (en) Hybrid cochlear implant
US20140163692A1 (en) Securable Implantable Component
EP3768376B1 (en) Implantable medical device structures including recharge and/or telemetry coil
WO2017034530A1 (en) Cochlear implant with a magnet restraint anchored to restraint anchors and a method for securing a magnet
US20100331913A1 (en) Hybrid multi-function electrode array
US10894156B2 (en) Implantable medical devices having resilient mounting tabs and associated methods
EP3765142B1 (en) Kit for securing burr hole plugs for stimulation systems
US10610690B2 (en) Fully implantable trial neurostimulation system configured for minimally-intrusive implant/explant
EP2456511B1 (en) Electrode having erectable lead
US8554339B2 (en) Anchor assembly for use in occipital nerve stimulation
US20210038896A1 (en) Devices and methods for improving headache disorders
EP3769809B1 (en) Vestibular stimulation prosthesis
US20060178720A1 (en) Method and apparatus for sealing a lumen in an electrode assembly
AU2003287772A1 (en) Method and apparatus for sealing a lumen in an electrode assembly

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180604

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20200511

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1322997

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201015

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015060509

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1322997

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201014

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20201014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210215

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210114

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210115

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210214

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210114

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015060509

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201105

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20201130

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201130

26N No opposition filed

Effective date: 20210715

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201214

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201105

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210214

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201130

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231127

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231129

Year of fee payment: 9